These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
[_]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3177549
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
Incorporation or Organization)
|
Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
Emerging growth company
o
|
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
Page
|
|
|
|
|
|
|
Financial Statements (Unaudited)
|
|
|
|
|
|
|
a) Condensed Consolidated Statements of Income for the three and nine months ended October 29, 2017 and October 30, 2016
|
|
|
|
|
|
b) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended October 29, 2017 and October 30, 2016
|
|
|
|
|
|
c) Condensed Consolidated Balance Sheets as of October 29, 2017 and January 29, 2017
|
|
|
|
|
|
d) Condensed Consolidated Statements of Cash Flows for the nine months ended October 29, 2017 and October 30, 2016
|
|
|
|
|
|
e) Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
||
|
|
|
Quantitative and Qualitative Disclosures About Market Risk
|
||
|
|
|
Controls and Procedures
|
||
|
|
|
|
|
|
|
|
|
Legal Proceedings
|
||
|
|
|
Risk Factors
|
||
|
|
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
||
|
|
|
Exhibits
|
||
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
|
|
October 30,
|
|
October 29,
|
|
October 30,
|
||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
2,636
|
|
|
$
|
2,004
|
|
|
$
|
6,803
|
|
|
$
|
4,737
|
|
Cost of revenue
|
1,067
|
|
|
821
|
|
|
2,782
|
|
|
1,977
|
|
||||
Gross profit
|
1,569
|
|
|
1,183
|
|
|
4,021
|
|
|
2,760
|
|
||||
Operating expenses
|
|
|
|
|
|
|
|
|
|||||||
Research and development
|
462
|
|
|
373
|
|
|
1,290
|
|
|
1,069
|
|
||||
Sales, general and administrative
|
212
|
|
|
171
|
|
|
594
|
|
|
487
|
|
||||
Restructuring and other charges
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
||||
Total operating expenses
|
674
|
|
|
544
|
|
|
1,884
|
|
|
1,559
|
|
||||
Income from operations
|
895
|
|
|
639
|
|
|
2,137
|
|
|
1,201
|
|
||||
Interest income
|
17
|
|
|
14
|
|
|
48
|
|
|
37
|
|
||||
Interest expense
|
(15
|
)
|
|
(16
|
)
|
|
(46
|
)
|
|
(39
|
)
|
||||
Other, net
|
(1
|
)
|
|
(16
|
)
|
|
(22
|
)
|
|
(19
|
)
|
||||
Total other income (expense)
|
1
|
|
|
(18
|
)
|
|
(20
|
)
|
|
(21
|
)
|
||||
Income before income tax expense
|
896
|
|
|
621
|
|
|
2,117
|
|
|
1,180
|
|
||||
Income tax expense
|
58
|
|
|
79
|
|
|
189
|
|
|
168
|
|
||||
Net income
|
$
|
838
|
|
|
$
|
542
|
|
|
$
|
1,928
|
|
|
$
|
1,012
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
1.39
|
|
|
$
|
1.01
|
|
|
$
|
3.23
|
|
|
$
|
1.89
|
|
Diluted
|
$
|
1.33
|
|
|
$
|
0.83
|
|
|
$
|
3.05
|
|
|
$
|
1.59
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares used in per share computation:
|
|
|
|
|
|
|
|
||||||||
Basic
|
603
|
|
|
538
|
|
|
597
|
|
|
536
|
|
||||
Diluted
|
628
|
|
|
653
|
|
|
633
|
|
|
636
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Cash dividends declared and paid per common share
|
$
|
0.140
|
|
|
$
|
0.115
|
|
|
$
|
0.420
|
|
|
$
|
0.345
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
|
|
October 30,
|
|
October 29,
|
|
October 30,
|
||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
|
|
|
|
|
||||||||||
Net income
|
$
|
838
|
|
|
$
|
542
|
|
|
$
|
1,928
|
|
|
$
|
1,012
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
|
|
|
||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
||||||||
Net unrealized gain (loss)
|
(3
|
)
|
|
(10
|
)
|
|
2
|
|
|
1
|
|
||||
Reclassification adjustments for net realized gain (loss) included in net income
|
1
|
|
|
—
|
|
|
1
|
|
|
1
|
|
||||
Net change in unrealized gain (loss)
|
(2
|
)
|
|
(10
|
)
|
|
3
|
|
|
2
|
|
||||
Cash flow hedges:
|
|
|
|
|
|
|
|
||||||||
Net unrealized gain (loss)
|
(1
|
)
|
|
2
|
|
|
(3
|
)
|
|
(3
|
)
|
||||
Reclassification adjustments for net realized gain (loss) included in net income
|
1
|
|
|
—
|
|
|
3
|
|
|
—
|
|
||||
Net change in unrealized gain (loss)
|
—
|
|
|
2
|
|
|
—
|
|
|
(3
|
)
|
||||
Other comprehensive income (loss), net of tax
|
(2
|
)
|
|
(8
|
)
|
|
3
|
|
|
(1
|
)
|
||||
Total comprehensive income
|
$
|
836
|
|
|
$
|
534
|
|
|
$
|
1,931
|
|
|
$
|
1,011
|
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
2,802
|
|
|
$
|
1,766
|
|
Marketable securities
|
3,518
|
|
|
5,032
|
|
||
Accounts receivable, net
|
1,167
|
|
|
826
|
|
||
Inventories
|
857
|
|
|
794
|
|
||
Prepaid expenses and other current assets
|
135
|
|
|
118
|
|
||
Total current assets
|
8,479
|
|
|
8,536
|
|
||
Property and equipment, net
|
600
|
|
|
521
|
|
||
Goodwill
|
618
|
|
|
618
|
|
||
Intangible assets, net
|
63
|
|
|
104
|
|
||
Other assets
|
70
|
|
|
62
|
|
||
Total assets
|
$
|
9,830
|
|
|
$
|
9,841
|
|
|
|
|
|
||||
LIABILITIES, CONVERTIBLE DEBT CONVERSION OBLIGATION AND SHAREHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
511
|
|
|
$
|
485
|
|
Accrued and other current liabilities
|
493
|
|
|
507
|
|
||
Convertible short-term debt
|
23
|
|
|
796
|
|
||
Total current liabilities
|
1,027
|
|
|
1,788
|
|
||
Long-term debt
|
1,985
|
|
|
1,983
|
|
||
Other long-term liabilities
|
464
|
|
|
271
|
|
||
Capital lease obligations, long-term
|
1
|
|
|
6
|
|
||
Total liabilities
|
3,477
|
|
|
4,048
|
|
||
Commitments and contingencies - see Note 12
|
|
|
|
|
|
||
Convertible debt conversion obligation
|
1
|
|
|
31
|
|
||
Shareholders’ equity:
|
|
|
|
||||
Preferred stock
|
—
|
|
|
—
|
|
||
Common stock
|
1
|
|
|
1
|
|
||
Additional paid-in capital
|
5,219
|
|
|
4,708
|
|
||
Treasury stock, at cost
|
(6,614
|
)
|
|
(5,039
|
)
|
||
Accumulated other comprehensive loss
|
(14
|
)
|
|
(16
|
)
|
||
Retained earnings
|
7,760
|
|
|
6,108
|
|
||
Total shareholders' equity
|
6,352
|
|
|
5,762
|
|
||
Total liabilities, convertible debt conversion obligation and shareholders' equity
|
$
|
9,830
|
|
|
$
|
9,841
|
|
|
Nine Months Ended
|
||||||
|
October 29,
|
|
October 30,
|
||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
1,928
|
|
|
$
|
1,012
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
145
|
|
|
140
|
|
||
Stock-based compensation expense
|
265
|
|
|
176
|
|
||
Deferred income taxes
|
158
|
|
|
146
|
|
||
Amortization of debt discount
|
3
|
|
|
20
|
|
||
Loss on early debt conversions
|
19
|
|
|
15
|
|
||
Net loss (gain) on sale and disposal of long-lived assets and investments
|
1
|
|
|
(2
|
)
|
||
Other
|
11
|
|
|
8
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(342
|
)
|
|
(328
|
)
|
||
Inventories
|
(61
|
)
|
|
(261
|
)
|
||
Prepaid expenses and other assets
|
(26
|
)
|
|
(28
|
)
|
||
Accounts payable
|
27
|
|
|
218
|
|
||
Accrued and other current liabilities
|
(15
|
)
|
|
(136
|
)
|
||
Other long-term liabilities
|
31
|
|
|
(29
|
)
|
||
Net cash provided by operating activities
|
2,144
|
|
|
951
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Proceeds from sales of marketable securities
|
802
|
|
|
1,239
|
|
||
Proceeds from maturities of marketable securities
|
739
|
|
|
712
|
|
||
Proceeds from sale of long-lived assets and investments
|
—
|
|
|
6
|
|
||
Purchases of marketable securities
|
(36
|
)
|
|
(2,249
|
)
|
||
Purchases of property and equipment and intangible assets
|
(177
|
)
|
|
(125
|
)
|
||
Investment in non-affiliates
|
(26
|
)
|
|
(3
|
)
|
||
Net cash provided by (used in) investing activities
|
1,302
|
|
|
(420
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from issuance of debt
|
—
|
|
|
1,988
|
|
||
Payments related to repurchases of common stock
|
(909
|
)
|
|
(509
|
)
|
||
Repayment of Convertible Notes
|
(803
|
)
|
|
(444
|
)
|
||
Dividends paid
|
(250
|
)
|
|
(185
|
)
|
||
Proceeds related to employee stock plans
|
132
|
|
|
148
|
|
||
Payments related to tax on restricted stock units
|
(577
|
)
|
|
(177
|
)
|
||
Other
|
(3
|
)
|
|
(8
|
)
|
||
Net cash provided by (used in) financing activities
|
(2,410
|
)
|
|
813
|
|
||
Change in cash and cash equivalents
|
1,036
|
|
|
1,344
|
|
||
Cash and cash equivalents at beginning of period
|
1,766
|
|
|
596
|
|
||
Cash and cash equivalents at end of period
|
$
|
2,802
|
|
|
$
|
1,940
|
|
|
|
|
|
||||
Other non-cash investing activity:
|
|
|
|
||||
Assets acquired by assuming related liabilities
|
$
|
20
|
|
|
$
|
25
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
2017 |
|
October 30,
2016 |
|
October 29,
2017 |
|
October 30,
2016 |
||||||||
|
(In millions)
|
||||||||||||||
Cost of revenue
|
$
|
6
|
|
|
$
|
2
|
|
|
$
|
14
|
|
|
$
|
10
|
|
Research and development
|
61
|
|
|
36
|
|
|
146
|
|
|
95
|
|
||||
Sales, general and administrative
|
40
|
|
|
27
|
|
|
105
|
|
|
71
|
|
||||
Total
|
$
|
107
|
|
|
$
|
65
|
|
|
$
|
265
|
|
|
$
|
176
|
|
|
RSUs, PSUs, and Market-based PSUs Outstanding
|
|
Options Outstanding
|
||||||||||
|
Number of Shares
|
|
Weighted Average Grant-Date Fair Value Per Share
|
|
Number of Shares
|
|
Weighted Average Exercise Price Per Share
|
||||||
|
(In millions, except per share data)
|
||||||||||||
Balances, January 29, 2017
|
27
|
|
|
$
|
32.84
|
|
|
7
|
|
|
$
|
14.47
|
|
Granted (1) (2)
|
6
|
|
|
$
|
142.34
|
|
|
—
|
|
|
$
|
—
|
|
Exercised
|
—
|
|
|
$
|
—
|
|
|
(2
|
)
|
|
$
|
14.46
|
|
Vested
|
(10
|
)
|
|
$
|
26.88
|
|
|
—
|
|
|
$
|
—
|
|
Balances, October 29, 2017
|
23
|
|
|
$
|
64.42
|
|
|
5
|
|
|
$
|
14.47
|
|
(1)
|
Includes PSUs that will be issued and eligible to vest if the corporate financial performance maximum target level for
fiscal year 2018
is achieved. Depending on the actual level of achievement of the corporate performance target at the end of
fiscal year 2018
, the PSUs issued could be up to
0.6 million
shares.
|
(2)
|
Includes market-based PSUs that will be issued and eligible to vest if the maximum target for total shareholder return, or TSR, over the 3-year measurement period is achieved. Depending on the ranking of our TSR compared to the respective TSRs of the companies comprising the Standard & Poor’s 500 Index during that period, the market-based PSUs issued could be up to
0.1 million
shares.
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
|
(In millions)
|
||||||
Aggregate unearned stock-based compensation expense
|
$
|
1,153
|
|
|
$
|
627
|
|
|
|
|
|
||||
Estimated weighted average remaining amortization period
|
(In years)
|
||||||
Stock options
|
—
|
|
|
0.5
|
|
||
RSUs, PSUs, and market-based PSUs
|
2.5
|
|
|
2.6
|
|
||
ESPP
|
0.7
|
|
|
0.6
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
|
|
October 30,
|
|
October 29,
|
|
October 30,
|
||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
(In millions, except per share data)
|
||||||||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
838
|
|
|
$
|
542
|
|
|
$
|
1,928
|
|
|
$
|
1,012
|
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
Basic weighted average shares
|
603
|
|
|
538
|
|
|
597
|
|
|
536
|
|
||||
Dilutive impact of outstanding securities:
|
|
|
|
|
|
|
|
||||||||
Equity awards
|
23
|
|
|
27
|
|
|
24
|
|
|
25
|
|
||||
1.00% Convertible Senior Notes
|
2
|
|
|
45
|
|
|
7
|
|
|
42
|
|
||||
Warrants issued with the 1.00% Convertible
Senior Notes
|
—
|
|
|
43
|
|
|
5
|
|
|
33
|
|
||||
Diluted weighted average shares
|
628
|
|
|
653
|
|
|
633
|
|
|
636
|
|
||||
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic (1)
|
$
|
1.39
|
|
|
$
|
1.01
|
|
|
$
|
3.23
|
|
|
$
|
1.89
|
|
Diluted (2)
|
$
|
1.33
|
|
|
$
|
0.83
|
|
|
$
|
3.05
|
|
|
$
|
1.59
|
|
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
|
3
|
|
|
7
|
|
|
4
|
|
|
9
|
|
(1)
|
Calculated as net income divided by basic weighted average shares.
|
(2)
|
Calculated as net income divided by diluted weighted average shares.
|
|
October 29, 2017
|
||||||||||||||||||||||
|
Amortized
Cost
|
|
Unrealized
Gain
|
|
Unrealized
Loss
|
|
Estimated
Fair Value
|
|
Reported as
|
||||||||||||||
|
|
|
|
|
Cash Equivalents
|
|
Marketable Securities
|
||||||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Corporate debt securities
|
$
|
1,515
|
|
|
$
|
—
|
|
|
$
|
(5
|
)
|
|
$
|
1,510
|
|
|
$
|
—
|
|
|
$
|
1,510
|
|
Debt securities of United States government agencies
|
907
|
|
|
—
|
|
|
(5
|
)
|
|
902
|
|
|
—
|
|
|
902
|
|
||||||
Debt securities issued by the United States Treasury
|
638
|
|
|
—
|
|
|
(3
|
)
|
|
635
|
|
|
—
|
|
|
635
|
|
||||||
Asset-backed securities
|
289
|
|
|
—
|
|
|
(1
|
)
|
|
288
|
|
|
—
|
|
|
288
|
|
||||||
Mortgage-backed securities issued by United States government-sponsored enterprises
|
140
|
|
|
2
|
|
|
(1
|
)
|
|
141
|
|
|
—
|
|
|
141
|
|
||||||
Foreign government bonds
|
42
|
|
|
—
|
|
|
—
|
|
|
42
|
|
|
—
|
|
|
42
|
|
||||||
Money market funds
|
2,609
|
|
|
—
|
|
|
—
|
|
|
2,609
|
|
|
2,609
|
|
|
—
|
|
||||||
Total
|
$
|
6,140
|
|
|
$
|
2
|
|
|
$
|
(15
|
)
|
|
$
|
6,127
|
|
|
$
|
2,609
|
|
|
$
|
3,518
|
|
|
January 29, 2017
|
||||||||||||||||||||||
|
Amortized
Cost |
|
Unrealized
Gain |
|
Unrealized
Loss |
|
Estimated
Fair Value |
|
Reported as
|
||||||||||||||
|
|
|
|
|
Cash Equivalents
|
|
Marketable Securities
|
||||||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Corporate debt securities
|
$
|
2,397
|
|
|
$
|
1
|
|
|
$
|
(10
|
)
|
|
$
|
2,388
|
|
|
$
|
33
|
|
|
$
|
2,355
|
|
Debt securities of United States government agencies
|
1,193
|
|
|
—
|
|
|
(5
|
)
|
|
1,188
|
|
|
27
|
|
|
1,161
|
|
||||||
Debt securities issued by the United States Treasury
|
852
|
|
|
—
|
|
|
(2
|
)
|
|
850
|
|
|
55
|
|
|
795
|
|
||||||
Asset-backed securities
|
490
|
|
|
—
|
|
|
(1
|
)
|
|
489
|
|
|
—
|
|
|
489
|
|
||||||
Mortgage-backed securities issued by United States government-sponsored enterprises
|
161
|
|
|
2
|
|
|
(1
|
)
|
|
162
|
|
|
—
|
|
|
162
|
|
||||||
Foreign government bonds
|
70
|
|
|
—
|
|
|
—
|
|
|
70
|
|
|
—
|
|
|
70
|
|
||||||
Money market funds
|
321
|
|
|
—
|
|
|
—
|
|
|
321
|
|
|
321
|
|
|
—
|
|
||||||
Total
|
$
|
5,484
|
|
|
$
|
3
|
|
|
$
|
(19
|
)
|
|
$
|
5,468
|
|
|
$
|
436
|
|
|
$
|
5,032
|
|
|
Less than 12 Months
|
|
12 Months or Greater
|
|
Total
|
||||||||||||||||||
|
Estimated Fair Value
|
|
Gross
Unrealized
Losses
|
|
Estimated Fair Value
|
|
Gross
Unrealized
Losses
|
|
Estimated Fair Value
|
|
Gross
Unrealized
Losses
|
||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Corporate debt securities
|
$
|
867
|
|
|
$
|
(3
|
)
|
|
$
|
407
|
|
|
$
|
(2
|
)
|
|
$
|
1,274
|
|
|
$
|
(5
|
)
|
Debt securities issued by United States government agencies
|
666
|
|
|
(3
|
)
|
|
236
|
|
|
(2
|
)
|
|
902
|
|
|
(5
|
)
|
||||||
Debt securities issued by the United States Treasury
|
509
|
|
|
(2
|
)
|
|
126
|
|
|
(1
|
)
|
|
635
|
|
|
(3
|
)
|
||||||
Asset-backed securities
|
233
|
|
|
(1
|
)
|
|
44
|
|
|
—
|
|
|
277
|
|
|
(1
|
)
|
||||||
Mortgage-backed securities issued by United States government-sponsored enterprises
|
26
|
|
|
—
|
|
|
36
|
|
|
(1
|
)
|
|
62
|
|
|
(1
|
)
|
||||||
|
$
|
2,301
|
|
|
$
|
(9
|
)
|
|
$
|
849
|
|
|
$
|
(6
|
)
|
|
$
|
3,150
|
|
|
$
|
(15
|
)
|
|
October 29, 2017
|
|
January 29, 2017
|
||||||||||||
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||||||
|
(In millions)
|
||||||||||||||
Less than 1 year
|
$
|
4,074
|
|
|
$
|
4,072
|
|
|
$
|
2,209
|
|
|
$
|
2,209
|
|
Due in 1 - 5 years
|
2,024
|
|
|
2,013
|
|
|
3,210
|
|
|
3,194
|
|
||||
Mortgage-backed securities issued by United States government-sponsored enterprises not due at a single maturity date
|
42
|
|
|
42
|
|
|
65
|
|
|
65
|
|
||||
Total
|
$
|
6,140
|
|
|
$
|
6,127
|
|
|
$
|
5,484
|
|
|
$
|
5,468
|
|
|
|
Fair Value at
|
|||||||
|
Pricing Category
|
|
October 29, 2017
|
|
January 29, 2017
|
||||
|
|
|
(In millions)
|
||||||
Assets
|
|
|
|
|
|
||||
Cash equivalents and marketable securities:
|
|
|
|
||||||
Corporate debt securities
|
Level 2
|
|
$
|
1,510
|
|
|
$
|
2,388
|
|
Debt securities of United States government agencies
|
Level 2
|
|
$
|
902
|
|
|
$
|
1,188
|
|
Debt securities issued by the United States Treasury
|
Level 2
|
|
$
|
635
|
|
|
$
|
850
|
|
Asset-backed securities
|
Level 2
|
|
$
|
288
|
|
|
$
|
489
|
|
Mortgage-backed securities issued by United States government-sponsored enterprises
|
Level 2
|
|
$
|
141
|
|
|
$
|
162
|
|
Foreign government bonds
|
Level 2
|
|
$
|
42
|
|
|
$
|
70
|
|
Money market funds
|
Level 1
|
|
$
|
2,609
|
|
|
$
|
321
|
|
|
|
|
|
|
|
||||
Liabilities
|
|
|
|
|
|
||||
Current liability:
|
|
|
|
|
|
||||
1.00% Convertible Senior Notes (1)
|
Level 2
|
|
$
|
245
|
|
|
$
|
4,474
|
|
Other noncurrent liabilities:
|
|
|
|
|
|
||||
2.20% Notes Due 2021 (1)
|
Level 2
|
|
$
|
996
|
|
|
$
|
975
|
|
3.20% Notes Due 2026 (1)
|
Level 2
|
|
$
|
1,007
|
|
|
$
|
961
|
|
Interest rate swap (2)
|
Level 2
|
|
$
|
3
|
|
|
$
|
2
|
|
(1)
|
The remaining
1.00%
Convertible Senior Notes,
2.20%
Notes Due 2021, and
3.20%
Notes Due 2026 are carried on our Condensed Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs, and are not marked to fair value each period. See Note 11 of these Notes to Condensed Consolidated Financial Statements for additional information.
|
(2)
|
Please refer to
Note 9
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.
|
|
October 29, 2017
|
|
January 29, 2017
|
||||||||||||||||||||
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
||||||||||||
|
(In millions)
|
||||||||||||||||||||||
Acquisition-related intangible assets
|
$
|
193
|
|
|
$
|
(178
|
)
|
|
$
|
15
|
|
|
$
|
193
|
|
|
$
|
(167
|
)
|
|
$
|
26
|
|
Patents and licensed technology
|
469
|
|
|
(421
|
)
|
|
48
|
|
|
468
|
|
|
(390
|
)
|
|
78
|
|
||||||
Total intangible assets
|
$
|
662
|
|
|
$
|
(599
|
)
|
|
$
|
63
|
|
|
$
|
661
|
|
|
$
|
(557
|
)
|
|
$
|
104
|
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
Inventories:
|
(In millions)
|
||||||
Raw materials
|
$
|
219
|
|
|
$
|
252
|
|
Work in-process
|
235
|
|
|
176
|
|
||
Finished goods
|
403
|
|
|
366
|
|
||
Total inventories
|
$
|
857
|
|
|
$
|
794
|
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
Accrued and Other Current Liabilities:
|
(In millions)
|
||||||
Customer related liabilities (1)
|
$
|
177
|
|
|
$
|
197
|
|
Accrued payroll and related expenses
|
153
|
|
|
137
|
|
||
Deferred revenue (2)
|
65
|
|
|
85
|
|
||
Warranty accrual (3)
|
18
|
|
|
8
|
|
||
Accrued royalties
|
16
|
|
|
7
|
|
||
Professional service fees
|
13
|
|
|
13
|
|
||
Taxes payable
|
11
|
|
|
4
|
|
||
Accrued restructuring and other charges (4)
|
8
|
|
|
13
|
|
||
Coupon interest on debt obligations
|
7
|
|
|
21
|
|
||
Leases payable
|
5
|
|
|
4
|
|
||
Contributions payable
|
4
|
|
|
4
|
|
||
Other
|
16
|
|
|
14
|
|
||
Total accrued and other current liabilities
|
$
|
493
|
|
|
$
|
507
|
|
(1)
|
Customer related liabilities include accrued customer programs, such as rebates and marketing development funds.
|
(2)
|
Deferred revenue primarily includes customer advances and deferrals related to license and service arrangements.
|
(3)
|
Please refer to
Note 10
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding warranties.
|
(4)
|
Please refer to
Note 15
of these Notes to Condensed Consolidated Financial Statements for a discussion regarding restructuring and other charges.
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
Other Long-Term Liabilities:
|
(In millions)
|
||||||
Deferred income tax liability
|
$
|
295
|
|
|
$
|
141
|
|
Income tax payable
|
116
|
|
|
96
|
|
||
Contributions payable
|
12
|
|
|
9
|
|
||
Employee benefits liability
|
11
|
|
|
10
|
|
||
Deferred revenue
|
10
|
|
|
4
|
|
||
Deferred rent
|
8
|
|
|
6
|
|
||
Licenses payable
|
7
|
|
|
1
|
|
||
Other
|
5
|
|
|
4
|
|
||
Total other long-term liabilities
|
$
|
464
|
|
|
$
|
271
|
|
|
October 29,
2017 |
|
January 29,
2017 |
||||
|
(In millions)
|
||||||
Designated as cash flow hedges
|
$
|
93
|
|
|
$
|
67
|
|
Not designated for hedge accounting
|
$
|
74
|
|
|
$
|
32
|
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
|
(In millions)
|
||||||
Balance at beginning of period
|
$
|
8
|
|
|
$
|
11
|
|
Additions
|
13
|
|
|
2
|
|
||
Deductions
|
(3
|
)
|
|
(5
|
)
|
||
Balance at end of period
|
$
|
18
|
|
|
$
|
8
|
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
|
(In millions)
|
||||||
1.00% Convertible Senior Notes
|
$
|
24
|
|
|
$
|
827
|
|
Unamortized debt discount (1)
|
(1
|
)
|
|
(31
|
)
|
||
Net carrying amount
|
$
|
23
|
|
|
$
|
796
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 29,
|
|
October 30,
|
|
October 29,
|
|
October 30,
|
||||||||
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
|
(In millions)
|
||||||||||||||
Contractual coupon interest expense
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
10
|
|
Amortization of debt discount
|
|
—
|
|
|
5
|
|
|
2
|
|
|
20
|
|
||||
Total interest expense related to Convertible Notes
|
|
$
|
—
|
|
|
$
|
8
|
|
|
$
|
2
|
|
|
$
|
30
|
|
|
|
Expected
Remaining Term (years)
|
|
Effective
Interest Rate
|
|
October 29, 2017
|
|
January 29, 2017
|
||||
|
|
|
|
|
|
(In millions)
|
||||||
2.20% Notes Due 2021
|
|
3.9
|
|
2.38%
|
|
$
|
1,000
|
|
|
$
|
1,000
|
|
3.20% Notes Due 2026
|
|
8.9
|
|
3.31%
|
|
1,000
|
|
|
1,000
|
|
||
Unamortized debt discount and issuance costs
|
|
|
|
|
|
(15
|
)
|
|
(17
|
)
|
||
Net carrying amount
|
|
|
|
|
|
$
|
1,985
|
|
|
$
|
1,983
|
|
|
GPU
|
|
Tegra Processor
|
|
All Other
|
|
Consolidated
|
||||||||
|
(In millions)
|
||||||||||||||
Three Months Ended October 29, 2017
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
2,217
|
|
|
$
|
419
|
|
|
$
|
—
|
|
|
$
|
2,636
|
|
Depreciation and amortization expense
|
$
|
32
|
|
|
$
|
9
|
|
|
$
|
9
|
|
|
$
|
50
|
|
Operating income (loss)
|
$
|
978
|
|
|
$
|
88
|
|
|
$
|
(171
|
)
|
|
$
|
895
|
|
|
|
|
|
|
|
|
|
||||||||
Three Months Ended October 30, 2016
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue
|
$
|
1,697
|
|
|
$
|
241
|
|
|
$
|
66
|
|
|
$
|
2,004
|
|
Depreciation and amortization expense
|
$
|
30
|
|
|
$
|
8
|
|
|
$
|
10
|
|
|
$
|
48
|
|
Operating income (loss)
|
$
|
678
|
|
|
$
|
17
|
|
|
$
|
(56
|
)
|
|
$
|
639
|
|
|
|
|
|
|
|
|
|
||||||||
Nine Months Ended October 29, 2017
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
5,676
|
|
|
$
|
1,084
|
|
|
$
|
43
|
|
|
$
|
6,803
|
|
Depreciation and amortization expense
|
$
|
88
|
|
|
$
|
27
|
|
|
$
|
30
|
|
|
$
|
145
|
|
Operating income (loss)
|
$
|
2,342
|
|
|
$
|
206
|
|
|
$
|
(411
|
)
|
|
$
|
2,137
|
|
|
|
|
|
|
|
|
|
||||||||
Nine Months Ended October 30, 2016
|
|
|
|
|
|
|
|
||||||||
Revenue
|
$
|
3,972
|
|
|
$
|
567
|
|
|
$
|
198
|
|
|
$
|
4,737
|
|
Depreciation and amortization expense
|
$
|
87
|
|
|
$
|
22
|
|
|
$
|
31
|
|
|
$
|
140
|
|
Operating income (loss)
|
$
|
1,405
|
|
|
$
|
(35
|
)
|
|
$
|
(169
|
)
|
|
$
|
1,201
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
2017 |
|
October 30,
2016 |
|
October 29,
2017 |
|
October 30,
2016 |
||||||||
|
(In millions)
|
||||||||||||||
Reconciling items included in "All Other" category:
|
|
|
|
|
|
|
|
||||||||
Unallocated revenue
|
$
|
—
|
|
|
$
|
66
|
|
|
$
|
43
|
|
|
$
|
198
|
|
Stock-based compensation expense
|
(107
|
)
|
|
(65
|
)
|
|
(265
|
)
|
|
(176
|
)
|
||||
Unallocated cost of revenue and operating expenses
|
(61
|
)
|
|
(53
|
)
|
|
(176
|
)
|
|
(156
|
)
|
||||
Acquisition-related costs
|
(3
|
)
|
|
(4
|
)
|
|
(11
|
)
|
|
(12
|
)
|
||||
Restructuring and other charges
|
—
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
||||
Contributions
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
(4
|
)
|
||||
Legal settlement costs
|
—
|
|
|
—
|
|
|
—
|
|
|
(16
|
)
|
||||
Total
|
$
|
(171
|
)
|
|
$
|
(56
|
)
|
|
$
|
(411
|
)
|
|
$
|
(169
|
)
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
|
|
October 30,
|
|
October 29,
|
|
October 30,
|
||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
(In millions)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Taiwan
|
$
|
864
|
|
|
$
|
747
|
|
|
$
|
2,140
|
|
|
$
|
1,696
|
|
Other Asia Pacific
|
612
|
|
|
309
|
|
|
1,409
|
|
|
660
|
|
||||
China
|
515
|
|
|
341
|
|
|
1,325
|
|
|
845
|
|
||||
United States
|
263
|
|
|
282
|
|
|
894
|
|
|
682
|
|
||||
Other Americas
|
187
|
|
|
154
|
|
|
480
|
|
|
360
|
|
||||
Europe
|
195
|
|
|
171
|
|
|
555
|
|
|
494
|
|
||||
Total revenue
|
$
|
2,636
|
|
|
$
|
2,004
|
|
|
$
|
6,803
|
|
|
$
|
4,737
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 29,
|
|
October 30,
|
|
October 29,
|
|
October 30,
|
||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
(In millions)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Gaming
|
$
|
1,561
|
|
|
$
|
1,244
|
|
|
$
|
3,774
|
|
|
$
|
2,712
|
|
Professional Visualization
|
239
|
|
|
207
|
|
|
679
|
|
|
610
|
|
||||
Datacenter
|
501
|
|
|
240
|
|
|
1,326
|
|
|
534
|
|
||||
Automotive
|
144
|
|
|
127
|
|
|
426
|
|
|
359
|
|
||||
OEM & IP
|
191
|
|
|
186
|
|
|
598
|
|
|
522
|
|
||||
Total revenue
|
$
|
2,636
|
|
|
$
|
2,004
|
|
|
$
|
6,803
|
|
|
$
|
4,737
|
|
|
|
October 29,
|
|
January 29,
|
||
|
|
2017
|
|
2017
|
||
Accounts Receivable:
|
|
|
|
|
||
Customer A
|
|
17
|
%
|
|
19
|
%
|
|
October 29,
|
|
January 29,
|
||||
|
2017
|
|
2017
|
||||
|
(In millions)
|
||||||
Balance at beginning of period
|
$
|
13
|
|
|
$
|
23
|
|
Restructuring and other charges
|
—
|
|
|
3
|
|
||
Cash payments
|
(5
|
)
|
|
(13
|
)
|
||
Balance at end of period
|
$
|
8
|
|
|
$
|
13
|
|
|
Three Months Ended
|
|
|
|
|
||||||||||||
|
October 29, 2017
|
|
July 30, 2017
|
|
October 30, 2016
|
|
Q/Q
|
|
Y/Y
|
||||||||
|
($ in millions, except per share data)
|
|
|
|
|
||||||||||||
Revenue
|
$
|
2,636
|
|
|
$
|
2,230
|
|
|
$
|
2,004
|
|
|
18
|
%
|
|
32
|
%
|
Gross margin
|
59.5
|
%
|
|
58.4
|
%
|
|
59.0
|
%
|
|
110 bps
|
|
|
50 bps
|
|
|||
Operating expenses
|
$
|
674
|
|
|
$
|
614
|
|
|
$
|
544
|
|
|
10
|
%
|
|
24
|
%
|
Income from operations
|
$
|
895
|
|
|
$
|
688
|
|
|
$
|
639
|
|
|
30
|
%
|
|
40
|
%
|
Net income
|
$
|
838
|
|
|
$
|
583
|
|
|
$
|
542
|
|
|
44
|
%
|
|
55
|
%
|
Net income per diluted share
|
$
|
1.33
|
|
|
$
|
0.92
|
|
|
$
|
0.83
|
|
|
45
|
%
|
|
60
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
October 29,
2017 |
|
October 30,
2016 |
|
October 29,
2017 |
|
October 30,
2016 |
||||
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of revenue
|
40.5
|
|
|
41.0
|
|
|
40.9
|
|
|
41.7
|
|
Gross profit
|
59.5
|
|
|
59.0
|
|
|
59.1
|
|
|
58.3
|
|
Operating expenses
|
|
|
|
|
|
|
|
||||
Research and development
|
17.5
|
|
|
18.6
|
|
|
19.0
|
|
|
22.6
|
|
Sales, general and administrative
|
8.0
|
|
|
8.5
|
|
|
8.7
|
|
|
10.3
|
|
Restructuring and other charges
|
—
|
|
|
—
|
|
|
—
|
|
|
0.1
|
|
Total operating expenses
|
25.5
|
|
|
27.1
|
|
|
27.7
|
|
|
33.0
|
|
Income from operations
|
34.0
|
|
|
31.9
|
|
|
31.4
|
|
|
25.3
|
|
Interest income
|
0.6
|
|
|
0.7
|
|
|
0.7
|
|
|
0.8
|
|
Interest expense
|
(0.6
|
)
|
|
(0.8
|
)
|
|
(0.7
|
)
|
|
(0.8
|
)
|
Other, net
|
—
|
|
|
(0.8
|
)
|
|
(0.3
|
)
|
|
(0.4
|
)
|
Total other income (expense)
|
—
|
|
|
(0.9
|
)
|
|
(0.3
|
)
|
|
(0.4
|
)
|
Income before income tax expense
|
34.0
|
|
|
31.0
|
|
|
31.1
|
|
|
24.9
|
|
Income tax expense
|
2.2
|
|
|
3.9
|
|
|
2.8
|
|
|
3.5
|
|
Net income
|
31.8
|
%
|
|
27.1
|
%
|
|
28.3
|
%
|
|
21.4
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
|
October 29,
2017 |
|
October 30,
2016 |
|
$
Change |
|
%
Change |
|
October 29,
2017 |
|
October 30,
2016 |
|
$
Change |
|
%
Change |
||||||||||||||
|
($ in millions)
|
||||||||||||||||||||||||||||
GPU
|
$
|
2,217
|
|
|
$
|
1,697
|
|
|
$
|
520
|
|
|
31
|
%
|
|
$
|
5,676
|
|
|
$
|
3,972
|
|
|
$
|
1,704
|
|
|
43
|
%
|
Tegra Processor
|
419
|
|
|
241
|
|
|
178
|
|
|
74
|
%
|
|
1,084
|
|
|
567
|
|
|
517
|
|
|
91
|
%
|
||||||
All Other
|
—
|
|
|
66
|
|
|
(66
|
)
|
|
(100
|
)%
|
|
43
|
|
|
198
|
|
|
(155
|
)
|
|
(78
|
)%
|
||||||
Total
|
$
|
2,636
|
|
|
$
|
2,004
|
|
|
$
|
632
|
|
|
32
|
%
|
|
$
|
6,803
|
|
|
$
|
4,737
|
|
|
$
|
2,066
|
|
|
44
|
%
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
|
October 29,
2017 |
|
October 30,
2016 |
|
$
Change
|
|
%
Change
|
|
October 29,
2017 |
|
October 30,
2016 |
|
$
Change |
|
%
Change |
||||||||||||||
|
($ in millions)
|
||||||||||||||||||||||||||||
Research and development expenses
|
$
|
462
|
|
|
$
|
373
|
|
|
$
|
89
|
|
|
24
|
%
|
|
$
|
1,290
|
|
|
$
|
1,069
|
|
|
$
|
221
|
|
|
21
|
%
|
Sales, general and administrative expenses
|
212
|
|
|
171
|
|
|
41
|
|
|
24
|
%
|
|
594
|
|
|
487
|
|
|
107
|
|
|
22
|
%
|
||||||
Restructuring and other charges
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
%
|
|
—
|
|
|
3
|
|
|
(3
|
)
|
|
(100
|
)%
|
||||||
Total operating expenses
|
$
|
674
|
|
|
$
|
544
|
|
|
$
|
130
|
|
|
24
|
%
|
|
$
|
1,884
|
|
|
$
|
1,559
|
|
|
$
|
325
|
|
|
21
|
%
|
Research and development expenses as a percentage of net revenue
|
18
|
%
|
|
19
|
%
|
|
|
|
|
|
|
|
19
|
%
|
|
23
|
%
|
|
|
|
|
||||||||
Sales, general and administrative expenses as a percentage of net revenue
|
8
|
%
|
|
9
|
%
|
|
|
|
|
|
|
|
9
|
%
|
|
10
|
%
|
|
|
|
|
||||||||
Restructuring and other charges as a percentage of net revenue
|
—
|
%
|
|
—
|
%
|
|
|
|
|
|
—
|
%
|
|
—
|
%
|
|
|
|
|
|
October 29, 2017
|
|
January 29, 2017
|
||||
|
(In millions)
|
||||||
Cash and cash equivalents
|
$
|
2,802
|
|
|
$
|
1,766
|
|
Marketable securities
|
3,518
|
|
|
5,032
|
|
||
Cash, cash equivalents and marketable securities
|
$
|
6,320
|
|
|
$
|
6,798
|
|
|
Nine Months Ended
|
||||||
|
October 29, 2017
|
|
October 30, 2016
|
||||
|
(In millions)
|
||||||
Net cash provided by operating activities
|
$
|
2,144
|
|
|
$
|
951
|
|
Net cash provided by (used in) investing activities
|
$
|
1,302
|
|
|
$
|
(420
|
)
|
Net cash provided by (used in) financing activities
|
$
|
(2,410
|
)
|
|
$
|
813
|
|
Period
|
|
Total Number of Shares Purchased (In millions)
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Program (In millions)
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (In billions)
|
||||
July 31, 2017 - August 27, 2017
|
|
—
|
|
$
|
—
|
|
|
—
|
|
$
|
1.97
|
|
August 28, 2017 - September 24, 2017
|
|
1
|
|
$
|
180.56
|
|
|
1
|
|
$
|
1.82
|
|
September 25, 2017 - October 29, 2017
|
|
—
|
|
$
|
—
|
|
|
—
|
|
$
|
1.82
|
|
Total
|
|
1
|
|
|
|
1
|
|
|
Exhibit No.
|
|
Exhibit Description
|
|
Schedule
/Form
|
|
File Number
|
|
Exhibit
|
|
Filing Date
|
31.1*
|
|
|
|
|
|
|
|
|
|
|
31.2*
|
|
|
|
|
|
|
|
|
|
|
32.1#*
|
|
|
|
|
|
|
|
|
|
|
32.2#*
|
|
|
|
|
|
|
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
NVIDIA Corporation
|
||
By:
|
/s/ Colette M. Kress
|
|
|
|
|
|
|
|
Colette M. Kress
|
||
|
Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|